(the "Company")
Grant of awards under the Company's Sharesave Schemes
On
The options granted under the Sharesave Schemes are subject to three year savings contracts. In accordance with the rules of the Sharesave Schemes, the option price for the Save As You Earn Scheme 2016 was based on the mid-market share price at close of business on the dealing day immediately prior to the issue of the invitation on
Including the PDMR referred to above, a total of 50 employees participated in the Company's 2025 Sharesave Scheme invitation, with a total of 178,890 Sharesave Schemes awards being granted on
The following notifications have been made in accordance with the requirements of the EU Market Abuse Regulation as part of
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
|
|
||||
|
2. |
Reason for the notification |
|||||
|
a) |
Position/status |
Chief Client Experience Officer |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
|
|
||||
|
b) |
LEI |
2138009VHA1WI2VKMA28 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of |
||||
|
b) |
Identification code |
ISIN: GB00BJV2F804 |
||||
|
c) |
Nature of the transaction |
Grant of options under the International Sharesave Plan 2016
|
||||
|
d) |
Price(s) and volume(s)
|
|
||||
|
e) |
Aggregated information - Aggregate volume - Price
|
n/a n/a
|
||||
|
f) |
Date of the transaction |
|
||||
|
g) |
Place of the transaction |
Outside a trading venue |
||||
|
|
|
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the